SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 2) - USD ($) |
Dec. 31, 2015 |
Dec. 31, 2014 |
|---|---|---|
| Concentration Risk [Line Items] | ||
| Accounts receivable | $ 203,000 | $ 5,750,000 |
| Accounts Receivable [Member] | Customer Concentration Risk [Member] | Astra Zeneca A B | ||
| Concentration Risk [Line Items] | ||
| Accounts receivable | $ 5,800,000 | |
| Accounts Receivable [Member] | Customer Concentration Risk [Member] | Bristol-Myers Squibb Company | ||
| Concentration Risk [Line Items] | ||
| Accounts receivable | $ 203,000 |
| X | ||||||||||
- Definition Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|